Ticker: ACHC

Acadia Healthcare

Healthcare Healthcare Medical - Care Facilities

Price 31.34

Reco Hold Potential 60 Risk 70 Updated 2026-10-27

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Acadia Healthcare operates in the healthcare sector, specializing in the provision of behavioral health services. The company primarily focuses on inpatient psychiatric care, residential treatment, and outpatient services. Its major business segments include acute care hospitals and outpatient facilities, with revenue generated mainly from patient services. Acadia Healthcare aims to address mental health issues through a range of treatment programs tailored to various patient needs.

Investment Profile

The investment profile of Acadia Healthcare suggests it may be more aligned with value investors, given its current financial metrics and market position. The stock exhibits characteristics that may appeal to those seeking stability rather than aggressive growth. The investment horizon could be medium-term, considering the company's operational challenges and market conditions. Liquidity is moderate, suitable for investors with basic experience in the healthcare sector.

Category: Healthcare Sector: Healthcare Industry: Medical - Care Facilities Investment style: Balanced Horizon: Medium-term Company type: Mid Cap

Fundamental metrics (experimental) Updated: 2026-10-27

EPS (TTM) — earnings per share for the last 12 months, $: -12.45
Revenue QoQ — quarter-over-quarter revenue growth: 4.5%
EPS surprise: 9.7%
20d volatility: 2.1%

AI recommendation changes

Date	Before	After	Reason
2026-10-27	Sell	Hold	Weak fundamentals and high risk offset positive momentum.
2026-10-19	Hold	Sell	Weak fundamentals and high risk limit upside potential.
2026-10-11	Sell	Hold	Weak fundamentals offset by recent positive momentum.
2026-10-01	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-09-24	Sell	Hold	Weak fundamentals and negative momentum raise significant risk.
2026-09-05	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-08-27	Sell	Hold	Positive momentum, but weak fundamentals raise concerns.
2026-08-19	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-07-27	Buy	Hold	Weak fundamentals offset by strong recent price momentum.
2026-07-20	Hold	Buy	Strong momentum, but fundamentals show significant weakness.
2026-06-19	Sell	Hold	Strong momentum but significant EPS loss raises concerns.
2026-06-11	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-05-24	Sell	Hold	Weak fundamentals and negative momentum raise significant concerns.
2026-05-16	Hold	Sell	Weak fundamentals and high volatility raise concerns.
2026-05-08	—	Hold	Weak fundamentals and negative momentum raise significant concerns.
2026-05-03	Sell	Hold	Компания демонстрирует значительный рост за последние 60 дней, однако отрицательный EPS и высокая волатильность могут указывать на риски. Рекомендуется удерживать акции до более ясных сигналов для покупки.
2026-05-01	Hold	Sell	Компания демонстрирует значительные колебания цен и отрицательный EPS, что указывает на финансовые проблемы. Недавнее падение цены на 8.35% также свидетельствует о высоком уровне риска.
2026-03-29	Hold	Sell	Компания демонстрирует высокую волатильность и негативные показатели EPS, что указывает на риски. Однако недавний рост за 60 дней может свидетельствовать о потенциальном восстановлении.
2026-02-12	—	Hold	Компания Acadia Healthcare показывает значительный рост за последние 5 и 20 дней, что может указывать на восстановление. Однако, стоит учитывать высокую волатильность и падение на более длительных периодах.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-09-28	Raymond James	Update	— → 39	28.09
2026-09-23	Leerink Partners	Target Raised	30 → 33	28.825
2026-07-30	Guggenheim	Target Raised	38 → 39	27.35
2026-07-30	Barclays	Target Raised	25 → 32	27.35
2026-07-20	Guggenheim	Target Raised	31 → 38	34.5
2026-07-14	KeyBanc	Target Raised	30 → 40	30.56
2026-07-09	UBS	Target Raised	31 → 39	32.2206
2026-06-03	Jefferies	Update	— → 30	24.42
2026-05-27	KeyBanc	Update	— → 30	23.49
2026-05-04	RBC Capital	Target Raised	28 → 31	29.75
2026-05-04	Guggenheim	Target Raised	26 → 31	27.85
2026-05-01	Cantor Fitzgerald	Target Raised	20 → 30	26.3251
2026-04-30	Barclays	Target Raised	20 → 25	28.26
2026-04-20	Jefferies	Target Raised	20 → 24.5	27.5589
2026-04-17	UBS	Target Raised	27 → 31	27.4052
2026-02-26	Raymond James	Update	— → 25	21.585
2026-02-26	Leerink Partners	Target Raised	— → 22	20.84
2026-02-23	Guggenheim	Target Lowered	27 → 22	16.79
2026-01-22	Jefferies	Update	— → 15	14.33
2026-01-14	RBC Capital	Target Lowered	19 → 17	12.36
2025-12-18	Mizuho Securities	Target Lowered	22 → 17	14.53
2025-12-04	Barclays	Target Lowered	17 → 14	14.69
2025-12-03	RBC Capital	Target Lowered	22 → 19	14.1405

News Page 1 of 1

Nothing yet